Warning Letter — Advance-Esthetic LLC
The FDA issued a warning letter to Advance-Esthetic LLC on August 25, 2026, following an evaluation by the Center for Devices and Radiological Health.
This affects Advance-Esthetic LLC, as well as regulatory and quality compliance departments within the aesthetic medical device industry.
The issuance of a warning letter from CDRH indicates that the FDA has identified significant regulatory violations, which typically involve device adulteration or misbranding. While the specific product details are limited in this excerpt, such enforcement actions often lead to import alerts, seizure of products, or injunctions if the underlying compliance issues are not remediated to the agency's satisfaction.
Review all marketing materials and product listings to ensure device claims align with cleared indications for use. Conduct a gap analysis between current device specifications and existing 510(k) clearances to identify potential misbranding or adulteration risks.
FDA Warning Letter issued to: Advance-Esthetic LLC. 08/25/2026 — Center for Devices and Radiological Health. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/advance-esthetic-llc-729267-08252026
Open in openFDA / FDA.gov